linkedin

About Samsung Biologics America

Samsung Biologics America is our U.S. subsidiary committed to providing trusted services to our clients and industry partners. As part of our expansion efforts, we have established the San Francisco R&D Center to support our CDO services and a New Jersey office to enable close communication with current and potential clients worldwide.

San Francisco R&D Center
600 Gateway Blvd., South San Francisco, CA 94080, USA
New Jersey Office
100 Challenger Rd, Ridgefield Park, NJ 07660, USA
Directions to Samsung Biologics America image
San Francisco
New Jersey
Watch the video Watch the video
Directions to Samsung Biologics America image
San Francisco
New Jersey
Watch the video Watch the video zoom in
The San Francisco R&D Center is currently equipped for high-quality cell line development in support of client pipelines. As your next-door CDMO partner, we help start your journey from gene to IND. Operations at the San Francisco R&D Center are tightly coordinated with Samsung Biologics headquarters based in Songdo, South Korea, so that our partners can have access to the full capabilities and capacity of a best-in-class global CDMO.

Service & Facility

The San Francisco R&D Center uses industry-standard equipment, including Cytena Single Cell Printer and Solentim Cell Metric, to perform Cell Line Development (CLD) as fast as 14 weeks (or 3.5 months). Samsung Biologics offers its own proprietary cell line development technology S-CHOice®, which builds on glutamine synthase (GS) knock-out Chinese hamster ovary (CHO) cell line technology and shows improved titers up to two-fold from the industry average, reaching above 7 g/L for standard monoclonal antibodies. Our high expression cell line maintains viability over 90% at day-21 in a fed-batch study, demonstrating effectiveness in producing high quality cell lines.

Service & Facility step image Service & Facility step image

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Fill out the form and learn more

Please sign up to view the post..
* Required
Privacy Policy
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION
닫기
With our R&D Center at the heart of the San Francisco biocluster, Samsung Biologics America provides cell line development services for your IND filing with a faster timeline and high quality to ensure successful commercialization throughout the entire process.